ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Soligenix Receives FDA Protocol Clearance of Phase 3 Clinical Trial of SGX942
May 04, 2017Soligenix announced it received US Food and Drug Administration (FDA) clearance to advance a pivotal Phase 3 clinical trial evaluating SGX942 (dusquetide) for the treatment of oral mucositis in head and neck cancer (HNC) patients being treated with chemor
Pharma Sources Insight January 2025
